enGene Therapeutics, Inc. (ENGN)

1.81 +0.03 (+1.69%) USD  |  NASDAQ  |  Aug 24, 16:00
1.84 +0.03 (+1.66%) After-Hours: 18:27
More

enGene Therapeutics PS Ratio (Forward)

PS Ratio (Forward) Chart

View PS Ratio (Forward) for ENGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio (Forward) Chart
Start Trial

Historical PS Ratio (Forward) Data

View and export this data back to . Start Trial.
Date Value
August 24, 2026 --

Forward PS Ratio Definition

Forward Price to Sales Ratio is the current stock price over the predicted sales per share. While similar to the price to sales ratio, this is a forward looking estimate of a company's sales.

Read full definition.

PS Ratio (Forward) Range, Past 5 Years

View PS Ratio (Forward) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio (Forward) Benchmarks

View PS Ratio (Forward) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Medicus Pharma Ltd. --
Sirona Biochem Corp. --
Xenon Pharmaceuticals, Inc. Upgrade
Psyence Biomedical Ltd. --